about
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.The Dose-Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations.Data distribution: normal or abnormal? What to do about it.Data distribution: normal or abnormal?Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus.Independent association of glucocorticoids with damage accrual in SLE.Validation of the Lupus Impact Tracker in an Australian patient cohort.Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens.Investigation of outcomes following recombinant activated FVII use for refractory bleeding during abdominal aortic aneurysm repair.Day or overnight transfusion in critically ill patients: does it matter?Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding.Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus.Adult serum cytokine concentrations and the persistence of asthma.JNK signalling in human and experimental renal ischaemia/reperfusion injury.Discordance of patient and physician health status concerns in systemic lupus erythematosus.Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.Adherence to asthma management guidelines by middle-aged adults with current asthmaUrinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosusAnalysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosusDevelopment of the Asia Pacific Lupus Collaboration cohortAnalysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosisPrevalence versus incidenceLongitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus
P50
Q30833127-05D34E85-9648-493C-869B-6FFD053F362EQ33755148-BDA5A866-C04D-4493-91F0-973F7231F5EEQ34356418-50D2F8C2-5269-4D8D-9AA0-AC1BB0ADFEEEQ34356436-EFE4EE2D-2B4A-43E1-B1E1-2B3371023B1AQ36188027-34DF30A6-0B39-4FF4-8635-F175A2A87CAFQ36315477-B767A146-5EA8-47B3-99C7-C0FA31CE5C24Q37121715-D9120D9F-8284-430F-8C60-D5AC7CABCDAFQ37314750-70EDACA4-D1AF-469F-ADFE-0DF497F0F67BQ37464030-594DCB9E-0F21-43F8-8082-1FE697A32C3AQ39496964-D942DAAE-FF7B-489A-9393-F2AD76FBB23AQ39663124-3B238C04-D4FF-432B-8DC9-64E46337F707Q43697535-F5543F17-1B7B-4287-87B5-16C685D14C20Q48117536-913ACA46-25E3-48D8-AEE9-FDD67B666317Q48378200-394D337D-8104-4D6B-8B32-68612B6282A3Q49830970-B87970A8-52CF-4CB9-8244-E5A91E66C181Q50977654-E1AF0C0D-AEE5-4442-ACC8-DFA8C69CD17EQ54433786-D97C832E-B950-4668-889D-A3F73A8D6BA0Q54653817-3268324D-6777-4697-9E7C-853545B8F8CEQ55401570-4C16D9AC-4D51-4C44-A8CB-043587242650Q57100302-3FA6D8E0-9266-49D2-A1AC-F490EB397E36Q57291047-168A3655-1D3C-4A42-BE31-15BF9BEC09AFQ58588970-C7A7803D-1125-4F18-A82D-7EC0A00D56CAQ58610580-545F8B2D-E0B2-4C2E-A0B6-1A783A78C36BQ59791080-296B5582-437E-4D26-BAB5-26F4F37D8E28Q60503226-996D854B-B2A5-4A9F-906B-50DE61C24521Q91256552-3FEF5C6B-2338-4EBE-87E9-6EF49F7BFFEB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rangi Kandane-rathnayake
@ast
Rangi Kandane-rathnayake
@en
Rangi Kandane-rathnayake
@es
Rangi Kandane-rathnayake
@nl
Rangi Kandane-rathnayake
@sl
type
label
Rangi Kandane-rathnayake
@ast
Rangi Kandane-rathnayake
@en
Rangi Kandane-rathnayake
@es
Rangi Kandane-rathnayake
@nl
Rangi Kandane-rathnayake
@sl
prefLabel
Rangi Kandane-rathnayake
@ast
Rangi Kandane-rathnayake
@en
Rangi Kandane-rathnayake
@es
Rangi Kandane-rathnayake
@nl
Rangi Kandane-rathnayake
@sl
P106
P1153
35247918800
P31
P496
0000-0001-5397-1482